Long deemed the #1 challenge in clinical trials, the recruitment and retention of patients continues to keep sponsors up at night. Find a partner to help aid you along your patient journey during our virtual Solutions Expo on August 7th: https://lnkd.in/eshKWaJR
Clinical Leader
Pharmaceutical Manufacturing
Erie, Pennsylvania 13,675 followers
A resource and forum to investigate and resolve the common struggles related to running effective clinical trials.
About us
The landscape of the life sciences industry is as vast and varied as the professionals who work in it. Some online resources aim to serve the entire space. We wish them luck. Instead, our goal is to be the most valuable resource for a specific segment of the industry – clinical research & trials – and the professionals who make their living there. The Clinical Leader community is not made up of generalists. They’re specialists, like us. We deliver in-depth content from authoritative authors and sources because that’s what our community demands. Our editors connect with and interview top clinical executives from pharmaceutical and biotech companies who share best practices, challenges faced and overcome, clinical trends, partnering strategies, and experiences implementing new technologies. Additionally, our Clinical Leader Live series of live events provides an interactive forum where sponsor companies talk about some of today's biggest challenges when managing clinical trials. Even better, the audience gets to ask questions during the presentation.
- Website
-
https://www.clinicalleader.com/
External link for Clinical Leader
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Erie, Pennsylvania
- Founded
- 1995
- Specialties
- Clinical Trials and CRO
Updates
-
The #FDA’s new guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies includes several changes from the previous guidance, but there are a few key areas where this new guidance falls short. https://lnkd.in/dr8p-_ES By Denise N. Bronner, Ph.D.
-
Explore 3 major barriers to clinical trial participation and discover how Scout's effective patient support services can help overcome these challenges during Kuno van der Post and KimberLee Heidmann's presentation at our Patient Recruitment & Retention Solutions Expo! Reserve your spot for the August 7th event: https://lnkd.in/eDHj-mSv Sponsored by Medical Research Network
-
-
Despite the psychedelics industry reeling from Lykos Therapeutics’ recent failed FDA hearing, MindMed is riding high after a positive End-of-Phase 2 (EOP2) meeting with the regulator that has set up the small biopharma for a Phase 3 trial of its LSD-based treatment for generalized anxiety disorder (GAD). MindMed CEO Robert Barrow shared the details with Chief Editor Dan Schell: https://lnkd.in/ehVBFswW
Defying Industry Setbacks, MindMed Advances Psychedelic To Phase 3
clinicalleader.com
-
Join Shruti Iyer and Charles Curran at Clinical Leader's Patient Recruitment and Retention Solutions Expo to learn how Oracle Life Sciences can help you achieve better study feasibility and high confidence in the eligibility of enrolled participants through their Patient Recruitment & Site Feasibility solution. Reserve your spot for the August 7th event: https://lnkd.in/eKwFAfDG Sponsored by Medical Research Network
-
-
WEBINAR TOMORROW! Join us July 23rd to watch IQVIA present a thorough overview of One Home for Sites, a platform that aggregates and connects the key systems and tasks a site needs to perform across all the clinical trials it is conducting. Learn more about the platform and the tech partners that have joined. 📅 Register today: https://lnkd.in/eGjGHW9v 🗣 Speakers: KK Rumrill, Sr. Director and General Manager, Site & Planning Suites, IQVIA Lesley Freese, Senior Product Manager, One Home for Sites, IQVIA Robert Osterhaus, Director, Global Technology Partners, IQVIA Technologies Beth Dickson, Partner Manager, Greenphire
-
-
In this week's issue, we'll explore Amgen's novel rare disease trial with new organ-specific flare definitions, how Australia and South Korea are emerging as clinical research hubs, why sponsors should obsess over clinical trial oversight, how to effectively conduct long-term follow-up studies, and other popular insights! Daniel Cimbora, Amgen | Akosua Mireku | Donna Dorozinsky, Just in Time GCP | Erin Finot, MS, MBA, IQVIA | Gunjan Bagla ✔, Amritt, Inc. | Scout | Dan Schell, Nicole M. Palmer, MS | Monica Jain | Marjorie Zettler, PhD, MPH, Accutar Biotech | Castor
Amgen's Novel Rare Disease Trial With New Organ-Specific Flare Definitions, South Korea and Australia On The Rise As Clinical Research Hubs and More
Clinical Leader on LinkedIn
-
Discover how robotic gloveless isolator sterile fill-finish (SFF) systems can accelerate early-phase drug development, ensuring enhanced sterility and streamlined processes for biopharma innovation. https://lnkd.in/eugdc-wj Source: PCI Pharma Services
Reducing Time To First-In-Human Trials With Robotic Sterile Fill-Finish Manufacturing Services
clinicalleader.com
-
Factor's Karl DORWART explores 4 common pitfalls in site start-up, with strategies to reduce delays, cut costs, increase standardization, and enable the faster commencement of more clinical trial sites: https://lnkd.in/eX93zMsj
When Site Start-Up Goes Wrong: 4 Contracting Pitfalls To Avoid
clinicalleader.com